IgA Fc receptors

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 177-204

  Monteiro, Renato C ^a   Van De Winkel, Jan G J ^b,c  

^a INSERM   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c GENMAB   (Netherlands)

Author keywords

FcR; Glomerulonephritis; IgA; Inflammation; Mucosal defense

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; CANCER GROWTH FACTOR; CELL RECEPTOR; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; SECRETORY IMMUNOGLOBULIN; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FC(ALPHA) RECEPTOR; IGA RECEPTOR; IMMUNOGLOBULIN A; LEUKOCYTE ANTIGEN;

ANTIBACTERIAL ACTIVITY; BINDING AFFINITY; BIOLOGY; BIOSYNTHESIS; CHROMOSOME 19; DENDRITIC CELL; ENDOCYTOSIS; EOSINOPHIL; GENETIC CODE; GLYCOSYLATION; HUMAN; IMMUNITY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN STRUCTURE; IN VIVO STUDY; KIDNEY DISEASE; KUPFFER CELL; LIGAND BINDING; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; MOUSE; MUCOSAL IMMUNITY;

ANIMALS; ANTIGENS, CD; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; MICE; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; RECEPTORS, FC; SIGNAL TRANSDUCTION;

EID: 0038153671     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141011     Document Type: Review

References (184)

1. Lawrence DA, Weigle WO, Spiegelberg HL. 1975. Immunoglobulins cytophilic for human lymphocytes, monocytes and neutrophils. J. Clin. Invest. 55:368-72
2. Gupta S, Platsoucas CD, Good RA. 1979. Receptors for IgA on a subpopulation of human B lymphocytes. Proc. Natl. Acad. Sci. USA 76:4025-28
3. Lum LG, Muchmore AV, Keren D, Decker J, Koski I, et al. 1979. A receptor for IgA on human T lymphocytes. J. Immunol. 122:65-69
4. Lum LG, Muchmore AV, O'Connor N, Strober W, Blaese RM. 1979. Fc receptors for IgA on human B, and human non-B, non-T lymphocytes. J. Immunol. 123:714-19
5. Fanger MW, Shen L, Pugh J, Bernier GM. 1980. Subpopulations of human peripheral granulocyes and monocytes express receptors for IgA. Proc. Natl. Acad. Sci. USA 77:3640-44
6. Cooper MD, Kincade PW, Bockman DE, Lawton AR. 1974. Origin, distribution and differentiation of IgA-producing cells. Adv. Exp. Med. Biol. 45:13-22
7. van Furth R, Schuit HR, Hijmans W. 1965. The immunological development of the human fetus. J. Exp. Med. 122:1173-88
8. Buckley RH, Dees SC, O'Fallon WM. 1968. Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics 41:600-11
9. Kerr MA. 1990. The structure and function of human IgA. Biochem. J. 271:285-96
10. Solomon A. 1980. Monoclonal immunoglobulins as biomarkers of cancer. Cancer Markers 1:57-87
11. Boehm MK, Woof JM, Kerr MA, Perkins SJ. 1999. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J. Mol. Biol. 286:1421-47
12. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. 2001. IgA and the IgA Fc receptor. Trends Immunol. 22:205-11
13. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. 1996. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. Apmis 104:321-38
14. Kutteh WH, Prince SJ, Mestecky J. 1982. Tissue origins of human polymeric and monomeric IgA. J. Immunol. 128:990-95
15. Crago SS, Kutteh WH, Moro I, Allansmith MR, Radl J, et al. 1984. Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J. Immunol. 132:16-18
16. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288:2222-26
17. Kang HS, Chin RK, Wang Y, Yu P, Wang J, et al. 2002. Signaling via LTβR on the lamina propria stromal cells of the gut is required for IgA production. Nat. Immunol. 3:576-82
18. Mostov KE. 1994. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 12:63-84
19. Norderhaug IN, Johansen FE, Schjerven H, Brandtzaeg P. 1999. Regulation of the formation and external transport of secretory immunoglobulins. Crit. Rev. Immunol. 19:481-508
20. Spieker-Polet H, Yam PC, Knight KL. 1993. Differential expression of 13 IgA-heavy chain genes in rabbit lymphoid tissues. J. Immunol. 150:5457-65
21. Mestecky J, Russell MW, Elson CO. 1999. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 44:2-5
22. Stokes CR, Soothill JF, Turner MW. 1975. Immune exclusion is a function of IgA. Nature 255:745-46
23. Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME. 1991. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc. Natl. Acad. Sci. USA 88:8796-800
24. Underdown BJ, Schiff JM. 1986. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4:389-417
25. Mazanec MB, Nedrud JG, Kaetzel CS, Lamm ME. 1993. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today 14:430-35
26. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104-7
27. Fujioka H, Emancipator SN, Aikawa M, Huang DS, Blatnik F, et al. 1998. Immunocytochemical colocalization of specific immunoglobulin A with Sendai virus protein in infected polarized epithelium. J. Exp. Med. 188:1223-29
28. Bomsel M. 1997. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 3:42-47
29. Bomsel M, Heyman M, Hocini H, Lagaye S, Belec L, et al. 1998. Intracellular neutralization of HIV transcytosis across fight epithelial barriers by anti-HIV envelope protein dlgA or IgM. Immunity 9:277-87
30. Robinson JK, Blanchard TG, Levine AD, Emancipator SN, Lamm ME. 2001. A mucosal IgA-mediated excretory immune system in vivo. J. Immunol. 166:3688-92
31. Geissmann F, Launay P, Pasquier B, Lepelletier Y, Leborgne M, et al. 2001. A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. J. Immunol. 166:346-52
32. Dittmar MT, Simmons G, Hibbitts S, O'Hare M, Louisirirotchanakul S, et al. 1997. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J. Virol. 71:8008-13
33. van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, et al. 2000. FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat. Med. 6:680-85
34. Klaus GG. 1979. Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen-antibody complexes. Immunology 37:345-51
35. Schaffer FM, Monteiro RC, Volanakis JE, Cooper MD. 1991. IgA deficiency. Immunodefic. Rev. 3:15-44
36. Ravetch IV, Kinet JP. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-92
37. Mostov KE, Verges M, Altschuler Y. 2000. Membrane traffic in polarized epithelial cells. Curr. Opin. Cell Biol. 12:483-90
38. Monteiro RC, Kubagawa H, Cooper MD. 1990. Cellular distribution, regulation, and biochemical nature of an Fcα receptor in humans. J. Exp. Med. 171:597-613
39. Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L. 1990. Expression cloning of a human Fc receptor for IgA. J. Exp. Med. 172:1665-72
40. Shibuya A, Sakamoto N, Shimizu Y, Shibuya K, Osawa M, et al. 2000. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1:441-46
41. Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG. 1982. IgA interaction with the asialoglycoprotein receptor. Proc. Natl. Acad. Sci. USA 79:6229-31
42. Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, et al. 2001. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194:417-25
43. Monteiro RC, Cooper MD, Kubagawa H. 1992. Molecular heterogeneity of Fcα receptors detected by receptor-specific monoclonal antibodies. J. Immunol. 148:1764-70
44. Kubagawa H, Shimada T, Shimo K, Lassoued K, Monteiro RC, Cooper MD. 1997. CD89 Workshop Panel Report. Leucocyte Typing VI:1028-29
45. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Garfiand GL, Kubagawa H. 1993. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J. Clin. Invest. 92:1681-85
46. Heystek HC, Moulon C, Woltman AM, Garonne P, van Kooten C. 2002. Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J. Immunol. 168:102-7
47. Sibille Y, Chatelain B, Staquet P, Merrill WW, Delacroix DL, Vaerman IP. 1989. Surface IgA and Fcα receptors on human alveolar macrophages from normal subjects and from patients with sarcoidosis. Am. Rev. Respir. Dis. 139:740-47
48. Patry C, Sibille Y, Lehuen A, Monteiro RC. 1996. Identification of Fcα receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J. Immunol. 156:4442-48
49. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, et al. 2001. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA- mediated activities. J. Immunol. 167:2651-56
50. Chevailler A, Monteiro RC, Kubagawa H, Cooper MD. 1989. Immunofluorescence analysis of IgA binding by human mononuclear cells in blood and lymphoid tissue. J. Immunol. 142:2244-49
51. Shen L, Lasser R, Fanger MW. 1989. My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. J. Immunol. 143:4117-22
52. Morton HC, van Zandbergen G, van Kooten C, Howard C J, van de Winkel JG, Brandtzaeg P. 1999. Immunoglobulin-binding sites of human FcαRI (CD89) and bovine Fcγ2R are located in their membrane-distal extracellular domains. J. Exp. Med. 189:1715-22
53. Hostoffer RW, Krukovets I, Berger M. 1993. Increased FcαR expression and IgA-mediated function on neutrophils induced by chemoattractants. J. Immunol. 150:4532-40
54. Hostoffer RW, Krukovets I, Berger M. 1994. Enhancement by tumor necrosis factor-alpha of Fcα receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes. J. Infect. Dis. 170:82-87
55. Nikolova EB, Russell MW. 1995. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J. Leukoc. Biol. 57:875-82
56. Maliszewski CR, Shen L, Fanger MW. 1985. The expression of receptors for IgA on human monocytes and calcitrioltreated HL-60 cells. J. Immunol. 135:3878-81
57. Shen L, Collins JE, Schoenborn MA, Maliszewski CR. 1994. Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. J. Immunol. 152:4080-86
58. Boltz-Nitulescu G, Willheim M, Spittler A, Leutmezer F, Tempfer C, Winkler S. 1995. Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1 α,25-dihydroxyvitamin d-3 and cytokines. J. Leukoc. Biol. 58:256-62
59. Gessl A, Willheim M, Spittler A, Agis H, Krugluger W, Boltz-Nitulescu G. 1994. Influence of tumour necrosis factor-alpha on the expression of Fc IgG and IgA receptors, and other markers by cultured human blood monocytes and U937 cells. Scand J. Immunol. 39:151-56
60. Reterink TJ, Levarht EW, Klar-Mohamad N, Van Es LA, Daha MR. 1996. Transforming growth factor-β 1 (TGF-beta 1) down-regulates IgA Fc-receptor (CD89) expression on human monocytes. Clin. Exp. Immunol. 103:161-66
61. Grossetete B, Launay P, Lehuen A, Jungers P, Bach JF, Monteiro RC. 1998. Down-regulation of Fcα receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int. 53:1321-35
62. Borkowski TA, Jouvin MH, Lin SY, Kinet IP. 2001. Minimal requirements for IgE-mediated regulation of surface FcεRI. J. Immunol. 167:1290-96
63. de Wit TP, Morton HC, Capel PJ, van de Winkel JG. 1995. Structure of the gene for the human myeloid IgA Fc receptor (CD89). J. Immunol. 155:1203-9
64. Kremer EJ, Kalatzis V, Baker E, Callen DF, Sutherland GR, Maliszewski CR. 1992. The gene for the human IgA Fc receptor maps to 19q13.4. Hum. Genet. 89:107-8
65. Wines BD, Hulett MD, Jamieson GP, Trist HM, Spratt JM, Hogarth PM. 1999. Identification of residues in the first domain of human Fcα receptor essential for interaction with IgA. J. Immunol. 162:2146-53
66. Arm IP, Nwankwo C, Austen KF. 1997. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J. Immunol. 159:2342-49
67. Borges L, Hsu ML, Fanger N, Kubin M, Cosman D. 1997. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159:5192-96
68. Colonna M, Nakajima H, Navarro F, Lopez-Botet M. 1999. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66:375-81
69. Cosman D, Fanger N, Borges L, Kubin M, Chin W, et al. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-82
70. Lanier LL. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-93
71. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, et al. 1997. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7:283-90
72. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. 1997. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158:5083-86
73. Samaridis J, Colonna M. 1997. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27:660-65
74. Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO. 1997. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr. Biol. 7:615-18
75. Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT. 2002. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 23:81-88
76. Zhang G, Young JR, Tregaskes CA, Sopp P, Howard CJ. 1995. Identification of a novel class of mammalian Fc gamma receptor. J. Immunol. 155:1534-41
77. Jandrot-Perms M, Busfield S, Lagrue AH, Xiong X, Debili N, et al. 2000. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 96:1798-807
78. Kubagawa H, Burrows PD, Cooper MD. 1997. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 94:5261-66
79. Hayami K, Fukuta D, Nishikawa Y, Yamashita Y, Inui M, et al. 1997, Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J. Biol. Chem. 272:7320-27
80. Park E, Itatani CA. 1992. Detection of Fc receptors for IgA on rat alveolar and peritoneal macrophages. Cell Immunol. 142:225-37
81. Stafford HA, Knight KL, Fanger MW. 1982. Receptors for IgA on rabbit lymphocytes. II. Characterization of their binding parameters for IgA. J. Immunol. 128:2201-5
82. Shimokawa T, Tsuge T, Okumura K, Ra C. 2000. Identification and characterization of the promoter for the gene encoding the human myeloid IgA Fc receptor (FcaR, CD89). Immunogenetics 51:945-54
83. Morton HC, Schiel AE, Janssen SW, van de Winkel JG. 1996. Alternatively spliced forms of the human myeloid Fcα receptor (CD89) in neutrophils. Immunogenetics 43:246-47
84. Pleass RJ, Andrews PD, Kerr MA, Woof JM. 1996. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils. Biochem. J. 318:771-77
85. Toyabe S, Kuwano Y, Takeda K, Uchiyama M, Abo T. 1997. IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells. Clin. Exp. Immunol. 110:226-32
86. van Dijk TB, Bracke M, Caldenhoven E, Raaijmakers JA, Lammers JW, et al. 1996. Cloning and characterization of FcaRb, a novel Fcα receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood 88:4229-38
87. Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM. 2001. The interaction of FcαRI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J. Immunol. 166:1781-89
88. Hulett MD, Hogarth PM. 1994. Molecular basis of Fc receptor function. Adv. Immunol. 57:1-127
89. Sondermann P, Huber R, Oosthuizen V, Jacob U. 2000. The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406:267-73
90. Garman SC, Wurzburg BA, Tarchevskaya SS, Kinet IP, Jardetzky TS. 2000. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRI α. Nature 406:259-66
91. Winter CC, Long EO. 1997. A Single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158:4026-28
92. Carayannopoulos L, Hexham JM, Capra JD. 1996. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1. J. Exp. Med. 183:1579-86
93. Pleass RJ, Dunlop JI, Anderson CM, Woof JM. 1999. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fcα receptor (FcαR) CD89. J. Biol. Chem. 274:23508-14
94. Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, et al. 1998. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J. Biol. Chem. 273:2260-72
95. Honorio-Franca AC, Launay P, Carneiro-Sampaio MM, Monteiro RC. 2001. Colostral neutrophils express Fcα receptors (CD89) lacking gamma chain association and mediate noninflammatory properties of secretory IgA. J. Leukoc. Biol. 69:289-96
96. Van Spriel AB, Leusen JHW, Vilé H, van de Winkel JGJ. 2002. Mac-1 (CD11b/CD18) as accessory molecule for Fcα receptor (CD89) binding of immunoglobulin A. J. Immunol. 169:3831-36
97. Bracke M, Dubois GR, Bolt K, Bruijnzeel PL, Vaerman JP, et al. 1997. Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J. Immunol. 159:1459-65
98. Bracke M, Nijhuis E, Lammers JW, Coffer PJ, Koenderman L. 2000. A critical role for PI 3-kinase in cytokine-induced Fcα-receptor activation. Blood 95:2037-43
99. Bracke M, Lammers JW, Coffer PJ, Koenderman L. 2001. Cytokine-induced inside-out activation of FcαR (CD89) is mediated by a single serine residue (S263) in the intracellular domain of the receptor. Blood 97:3478-83
100. Launay P, Grossetete B, Arcos-Fajardo M, Gaudin E, Torres SP, et al. 2000. Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J. Exp. Med. 191:1999-2009
101. van Zandbergen G, Westerhuis R, Mohamad NK, van De Winkel JG, Daha MR, van Kooten C. 1999. Crosslinking of the human Fc receptor for IgA (FcαRI/CD89) triggers FcR α-chain-dependent shedding of soluble CD89. J. Immunol. 163:5806-12
102. van der Boog PJ, van Zandbergen G, de Fijter JW, Klar-Mohamad N, van Seggelen A, et al. 2002. FcαRI/CD89 circulates in human serum covalently linked to IgA in a polymeric state. J. Immunol. 168:1252-58
103. Pfefferkorn LC, Yeaman GR. 1994. Association of IgA-Fc receptors (FcαR) with FcεRI γ2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of γ2. J. Immunol. 153:3228-36
104. Reth M. 1989. Antigen receptor tail clue. Nature 338:383-84
105. Morton HC, van den Herik-Oudijk IE, Vossebeld P, Snijders A, Verhoeven AJ, et al. 1995. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR γ chain. Molecular basis for CD89/FcR gamma chain association. J. Biol. Chem. 270:29781-87
106. Launay P, Patry C, Lehuen A, Pasquier B, Blank U, Monteiro RC. 1999. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRγ association and protects against degradation of bound ligand. J. Biol. Chem. 274:7216-25
107. van Egmond M, van Vuuren AJ, Morton HC, van Spriel AB, Shen L, et al. 1999. Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ chain and CR3 (CD11b/CD18). Blood 93:4387-94
108. Lang ML, Shen L, Wade WF. 1999. Gamma-chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor FcαR. J. Immunol. 163:5391-98
109. Lang ML, Chen YW, Shen L, Gao H, Lang GA, et al. 2002. IgA Fc receptor (FcαR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts. Biochem. J. 364:517-25
110. Gulle H, Samstag A, Eibl MM, Wolf HM. 1998. Physical and functional association of FcαR with protein tyrosine kinase Lyn. Blood 91:383-91
111. Launay P, Lehuen A, Kawakami T, Blank U, Monteiro RC. 1998. IgA Fc receptor (CD89) activation enables coupling to syk and Btk tyrosine kinase pathways: differential signaling after IFN-γ or phorbol ester stimulation. J. Leukoc. Biol. 63:636-42
112. Park RK, Izadi KD, Deo YM, Durden DL. 1999. Role of Src in the modulation of multiple adaptor proteins in FcαRI oxidant signaling. Blood 94:2112-20
113. yRIIIb generate intracellular calcium signals which trigger the respiratory burst. Biochem. Soc. Trans. 25:S333
114. Lang ML, Kerr MA. 2000. Characterization of FcαR-triggered Ca(2+) signals: role in neutrophil NADPH oxidase activation. Biochem. Biophys. Res. Commun. 276:749-55
115. Ouadrhiri Y, Pilette C, Monteiro RC, Vaerman IP, Sibille Y. 2002. Effect of IgA on respiratory burst and cytokine release by human alveolar macrophages: role of ERK1/2 mitogen-activated protein kinases and NF-kappaB. Am. J. Respir. Cell. Mol. Biol. 26:315-32
116. Lang ML, Shen L, Gao H, Cusack WF, Lang GA, Wade WF. 2001. Fcα receptor cross-linking causes translocation of phosphatidylinositol-dependent protein kinase 1 and protein kinase B alpha to MHC class II peptide-loading-like compartments. J. Immunol. 166:5585-93
117. Daeron M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-34
118. Ravetch JV, Bolland S. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275-90
119. Shen L, van Egmond M, Siemasko K, Gao H, Wade T, et al. 2001. Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor γ-chain signaling. Blood 97:205-13
120. Burnett D, Chamba A, Stockley RA, Murphy TF, Hill SL. 1993. Effects of recombinant GM-CSF and IgA opsonisation on neutrophil phagocytosis of latex beads coated with p6 outer membrane protein from Haemophilus influenzae. Thorax 48:638-42
121. Gorter A, Hiemstra PS, Leijh PC, van der Sluys ME, van den Barselaar MT, et al. 1987. IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. Immunology 61:303-9
122. Weisbart RH, Kacena A, Schuh A, Golde DW. 1988. GM-CSFinduces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 332:647-48
123. Yeaman GR, Kerr MA. 1987. Opsonization of yeast by human serum IgA antimannan antibodies and phagocytosis by human polymorphonuclear leucocytes. Clin. Exp. Immunol. 68:200-8
124. Lowell GH, Smith LF, Griffiss JM, Brandt BL. 1980. IgA-dependent, monocyte-mediated, antibacterial activity. J. Exp. Med. 152:452-57
125. Dunne DW, Richardson BA, Jones FM, Clark M, Thome KJI, Butterworth AE. 1993. The use of Mouse/Human chimaeric antibodies to investigate the roles of different antibody isotypes, including IgA2, in the killing of Schistosoma mansoni schistosomula by eosinophils. Parasite Immunol. 15:181-85
126. Clark DA, Dessypris EN, Jenkins DE Jr, Krantz SB. 1984. Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms. Blood 64:1000-5
127. van Egmond M, van Spriel AB, Vermeulen H, Huls G, van Garderen E, van de Winkel JG. 2001. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of FcγRI (CD64) and FcαRI (CD89). Cancer Res. 61:4055-60
128. Deo YM, Sundarapandiyan K, Keler T, Wallace PK, Graziano RF. 1998. Bispecific molecules directed to the Fc receptor for IgA (FcαRI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood. J. Immunol. 160:1677-86
129. Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, et al. 1997. FcαRI (CD89) as a novel trigger molecule for bispecific antibody therapy. Blood 90:4485-92
130. Stockmeyer B, Dechant M, van Egmond M, Tutt AL, Sundarapandiyan K, et al. 2000. Triggering Fcα-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 165:5954-61
131. Zhang W, Lachmann PJ. 1996. Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fcα receptors or by complement receptors through different pathways. J. Immunol. 156:2599-606
132. Janoff EN, Fasching C, Orenstein IM, Rubins JB, Opstad NL, Dalmasso AP. 1999. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes. J. Clin. Invest. 104:1139-47
133. van Spriel AB, Leusen JH, van Egmond M, Dijkman HB, Assmann KI, et al. 2001. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formarion. Blood 97:2478-86
134. Patry C, Herbelin A, Lehuen A, Bach JF, Monteiro RC. 1995. Fcα receptors mediate release of tumour necrosis factor-α and interleukin-6 by human monocytes following receptor aggregation. Immunology 86:1-5
135. Deviere J, Vaerman IP, Content J, Denys C, Schandene L, et al. 1991. IgA triggers tumor necrosis factor alpha secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis. Hepatology 13:670-75
136. Ferreri NR, Howland WC, Spiegelberg HL. 1986. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. J. Immunol. 136:4188-93
137. Foreback JL, Remick DG, Crockett-Torabi E, Ward PA. 1997. Cytokine responses of human blood monocytes stimulated with Igs. Inflammation 21:501-17
138. Polat GL, Laufer J, Fabian I, Passwell JH. 1993. Cross-linking of monocyte plasma membrane Fcα, Fcγ or mannose receptors induces TNF production. Immunology 80:287-92
139. Shen L, Collins J. 1989. Monocyte superoxide secretion triggered by human IgA. Immunology 68:491-96
140. Mackenzie SJ, Kerr MA. 1995. IgM monoclonal antibodies recognizing FcαR but not FcγRIII trigger a respiratory burst in neutrophils although both trigger an increase in intracellular calcium levels and degranulation. Biochem. J. 306:519-23
141. Shen L. 1992. A monoclonal antibody specific for immunoglobulin A receptor triggers polymorphonuclear neutrophil superoxide release. J. Leukoc. Biol. 51:373-78
142. Stewart WW, Kerr MA. 1990. The specificity of the human neutrophil IgA receptor (FcαR) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Immunology 71:328-34
143. Stewart WW, Mazengera RL, Shen L, Kerr MA. 1994. Unaggregated serum IgA binds to neutrophil FcαR at physiological concentrations and is endocytosed but cross-linking is necessary to elicit a respiratory burst. J. Leukoc. Biol. 56:481-87
144. Zhang W, Voice J, Lachmann PJ. 1995. A systematic study of neutrophil degranulation and respiratory burst in vitro by defined immune complexes. Clin. Exp. Immunol. 101:507-14
145. Huls G, Heijnen IA, Cuomo E, van der Linden J, Boel E, et al. 1999. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies. Cancer Res. 59:5778-84
146. Dechant M, Valerius T. 2001. IgA antibodies for cancer therapy. Crit. Rev. Oncol. Hematol. 39:69-77
147. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, et al. 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4:601-6
148. van Dijk MA, van de Winkel JG. 2001. Human antibodies as next generation therapeutics. Curr. Opin. Chem. Biol. 5:368-74
149. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. 1989. IgA-induced eosinophil degranulation. J. Immunol. 142:2393-400
150. Lamkhioued B, Gounni AS, Gruart V, Pierce A, Capron A, Capron M. 1995. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation. Eur. J. Immunol. 25:117-25
151. Honorio-Franca AC, Carvalho MP, Isaac L, Trabulsi LR, Carneiro-Sampaio MM. 1997. Colostral mononuclear phagocytes are able to kill enteropathogenic Escherichia coli opsonized with colostral IgA. Scand. J. Immunol. 46:59-66
152. van Egmond M, Hanneke van Vuuren AJ, van de Winkel JG. 1999. The human Fc receptor for IgA (FcαRI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis. Immunol. Lett. 68:83-87
153. Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG. 2001. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect. Immun. 69:4846-50
154. van Spriel AB, van den Herik-Oudijk IE, van Sorge NM, Vile HA, van Strijp JA, van de JA, Winkel JG. 1999. Effective phagocytosis and killing of Candida albicans via targeting FcαRI (CD64) or FcαRI (CD89) on neutrophils. J. Infect. Dis. 179:661-69
155. van der Pol W, Vidarsson G, Vile HA, van de Winkel JG, Rodriguez ME. 2000. Pneumococcal capsular polysaccharide-specific IgA triggers efficient neutrophil effector functions via FcαRI (CD89). J Infect. Dis. 182:1139-45
156. Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, van de Winkel JG. 2001. Fc receptor-mediated immunity against Bordetella pertussis. J. Immunol. 167:6545-51
157. Vidarsson G, van der Pol WL, van den Elsen JMH, Vilé, Jansen M, et al. 2001. Activity of human IgG and IgA subclasses in immune defense against meningitidis serogroup B. J. Immmunol. 166:6250-56
158. Chiamolera M, Launay P, Montenegro V, Rivero MC, Velasco IT, Monteiro RC. 2001. Enhanced expression of Fcα receptor I on blood phagocytes of patients with gram-negative bacteremia is associated with tyrosine phosphorylation of the FcR-y subunit. Shock 16:344-48
159. Fayette J, Dubois B, Vandenabeele S, Bridon JM, Vanbervliet B, et al. 1997. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA(1) and IgA(2). J. Exp. Med. 185:1909-18
160. Sakamoto N, Shibuya K, Shimizu Y, Yotsumoto K, Miyabayashi T, et al. 2001. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur. J. Immunol. 31:1310-16
161. McDonald KI, Cameron AJ, Allen JM, Jardine AG. 2002. Expression of Fc α/μ receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem. Biophys. Res. Commun. 290:438-42
162. Tomana M, Kulhavy R, Mestecky J. 1988. Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94:762-70
163. Schiff JM, Huling SL, Jones AL. 1986. Receptor-mediated uptake of asialogly - coprotein by the primate liver initiates both lysosomal and transcellular pathways. Hepatology 6:837-47
164. Stockert RJ. 1995. The asialoglyco-protein receptor: relationships between structure, function, and expression. Physiol. Rev. 75:591-609
165. Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. 2000. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J. Exp. Med. 191:2171-82
166. Sjoberg O. 1980. Presence of receptors for IgA on human T and non-T lymphocytes. Eur. J. Immunol. 10:226-28
167. Endoh M, Sakai H, Nomoto Y, Tomino Y, Kaneshige H. 1981. IgA-specific helper activity of Ta cells in human peripheral blood. J. Immunol. 127:2612-13
168. Millet I, Briere F, Vincent C, Rousset F, Andreoni C, et al. 1989. Spontaneous expression of a low affinity Fc receptor for IgA (FcαR) on human B cell lines. Clin. Exp. Immunol. 76:268-73
169. Rudd PM, Fortune F, Patel T, Parekh RB, Dwek RA, Lehner T. 1994. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD. Immunology 83:99-106
170. Swenson CD, Patel T, Parekh RB, Tamma SM, Coico RF, et al. 1998. Human T cell IgD receptors react with O-glycans on both human IgD and IgA1. Eur. J. Immunol. 28:2366-72
171. Coico RF, Xue B, Wallace D, Pernis B, Siskind GW, Thorbecke GJ. 1985. T cells with receptors for IgD. Nature 316:744-46
172. Iikura M, Yamaguchi M, Fujisawa T, Miyamasu M, Takaishi T, et al. 1998. Secretory IgA induces degranulation of IL-3-primed basophils. J. Immunol. 161:1510-15
173. Mantis NJ, Cheung MC, Chintalacharuvu KR, Rey J, Corthésy B, Neutra MR. 2002. Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J. Immunol. 169:1844-51
174. Monteiro RC, Grossetete B, Nguyen AT, Jungers P, Lehuen A. 1995. Dysfunctions of Fcα receptors by blood phagocytic cells in IgA nephropathy. Contrib. Nephrol. 111:116-22
175. Silvain C, Patty C, Launay P, Lehuen A, Monteiro RC. 1995. Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-γ. J. Immunol. 155:1606-18
176. Novak J, Julian BA, Tomana M, Mestecky J. 2001. Progress in molecular and genetic studies of IgA nephropathy. J. Clin. Immunol. 21:310-27
177. van Zandbergen G, van Kooten C, Mohamad NK, Reterink TJ, de Fijter JW, et al. 1998. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89. Nephrol. Dial. Transplant. 13:3058-64
178. Phillips-Quagliata JM, Patel S, Han JK, Arakelov S, Rao TD, et al. 2000. The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor. J. Immunol. 165:2544-55
179. Grossetete B, Viard JP, Lehuen A, Bach JF, Monteiro RC. 1995. Impaired Fcα receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients. AIDS 9:229-34
180. Montenegro V, Chiamolera M, Launay P, Goncalves CR, Monteiro RC. 2000. Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis. J. Rheumatol. 27:411-17
181. Kashem A, Endoh M, Nomoto Y, Sakai H, Nakazawa H. 1996. Monocyte superoxide generation and its IgA-receptor in IgA nephropathy. Clin. Nephrol. 45:1-9
182. Monteiro RC, Moura IC, Launay P, Tsuge T, Haddad E, et al. 2002. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol. Med. 8:464-68
183. Couser WG. 1999. Glomemlonephritis. Lancet 353:1509-15
184. Nahm DH, Kim HY, Park HS. 1998. Elevation of specific immunoglobulin A antibodies to both allergen and bacterial antigen in induced sputum from asthmatics. Eur. Respir. J. 12:540-45